Botulinum toxin: Clinical use

This publication has 305 references indexed in Scilit:

• A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot
  Neurological Sciences, 2005
• Treatment of facial chromhidrosis with botulinum toxin type A
  Journal of the American Academy of Dermatology, 2005
• Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteers
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
• Botulinum toxin treatment of occupational and focal hand dystonia
  Movement Disorders, 2004
• Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study
  The Journal of Headache and Pain, 2003
• DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1
  Movement Disorders, 1997
• Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter
  Digestive Diseases and Sciences, 1996
• Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
  Movement Disorders, 1996
• A randomized, double‐blind, placebo‐controlled study to evaluate botulinum toxin type A in essential hand tremor
  Movement Disorders, 1996
• Treatment of spasticity with botulinum toxin: A double‐blind study
  Annals of Neurology, 1990